Cambodia vs Zambia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cambodia
0.4%
in 2024
Zambia
0.4%
in 2024
Cambodia rank
59th
Zambia rank
59th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cambodia
- Zambia
How they compare
Cambodia currently reports 0.4% against 0.4% in Zambia, a difference of 0.0%.
Across all 10 years both countries report, Zambia has been ahead every year.
Cambodia ranks 59th and Zambia ranks 59th of 215 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.6% | 0.2% | Zambia |
| 2020s | 0.4% | 0.4% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cambodia or Zambia?
- Cambodia, at 0.4% against 0.4% in Zambia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cambodia and Zambia?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Zambia?
- 10 years are reported by both, from 2015 to 2024.
- How do Cambodia and Zambia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cambodia ranks 59th and Zambia ranks 59th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.